Skip to main content

Advertisement

Table 3 Impact of concomitant peripheral arthritis on patient-reported outcomes and days of sick leave during the 5-year follow-up period in patients with recent onset axial spondyloarthritis

From: Evaluation of concomitant peripheral arthritis in patients with recent onset axial spondyloarthritis: 5-year results from the DESIR cohort

  Any arthritis
n = 255
mean (SD)*
No arthritis
n = 453
mean (SD)
Crude p value p value adjusted for TNFb p value adjusted for csDMARDs
BASDAI 40.46 (22.6) 34.30 (20.7) < 0.001 0.001 < 0.001
BASFI 27.89 (23.2) 22.52 (21.0) 0.001 0.049 0.011
SF36-MCS 42.17 (11.7) 43.99 (11.0) 0.003 0.059 0.022
SF36-PCS 40.93 (9.65) 43.09 (9.19) < 0.001 0.056 0.015
Days of sick leave 17.97 (57.5) 12.78 (47.2) 0.024 0.451 0.143
  1. p value for mixed model with random effects. All results are presented as mean and standard deviation
  2. *Mean value observed over time
  3. BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional Index, csDMARDs synthetic disease-modifying anti-rheumatic drugs, SF36-MCS mental component of the SF36 questionnaire, SF36-PCS physical component of the SF36 questionnaire, TNFb tumour necrosis factor blockers